Pharmacotherapy of Dysthymia
- 1 November 1993
- journal article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 23 (11) , 638-648
- https://doi.org/10.3928/0048-5713-19931101-11
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Prevalence and comorbidity of dysthymic disorder among psychiatric outpatientsJournal of Affective Disorders, 1992
- MOCLOBEMIDE COMPARED WITH IMIPRAMINE IN THE TREATMENT OF CHRONIC DEPRESSION (DYSTHYMIA DSM-III-R). A DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL.Clinical Neuropharmacology, 1992
- Ritanserin and flupenthixol in dysthymic disorder: A controlled double-blind study in general practiceNordic Journal of Psychiatry, 1992
- Biological studies of DysthymiaBiological Psychiatry, 1991
- Pharmacotherapy of DysthymiaJournal of Clinical Psychopharmacology, 1991
- 5‐HT2 receptor antagonism in dysthymic disorder: a double‐blind placebo‐controlled study with ritanserinActa Psychiatrica Scandinavica, 1991
- Efficacy of Tianeptine in Anxious-Depressed Patients: Results of a Controlled Multicenter Trial versus AmitriptylineNeuropsychobiology, 1989
- Double-Blind Study of Imipramine versus Phenelzine in Melancholias and Dysthymic DisordersThe British Journal of Psychiatry, 1987
- Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin‐S2 receptor blockerDrug Development Research, 1986
- The chronic depressive in the community: Unrecognized and poorly treatedComprehensive Psychiatry, 1977